Venetoclax: Everything You Need To Know image

Venetoclax: Everything You Need To Know

Nov 11, 2024
11:30AM - 12:30PM EST
Online Event
Overview

HealthTree Foundation for AML is hosting an informative virtual roundtable focused on venetoclax, a key drug used in the treatment of Acute Myeloid Leukemia (AML). This roundtable will cover what venetoclax is, how it treats AML and how it is dosed. Designed for both patients and caregivers, this roundtable will provide valuable insights and answer common questions about this important therapy. We will have a 15-minute Q&A with our 2 panelists at the end, so come prepared with all of your questions!

Agenda
11:30 AM
Introduction
Mary Arnett

Mary introduces the agenda for the event and featured speakers Dr. Catherine Lai and Dr. Gabriel Mannis

11:35 AM
Presentation
Catherine Lai, MD, MPH

Dr. Catherine Lai will answer the question "What is venetoclax and how does it work?"

11:55 AM
Presentation
Gabriel Mannis, MD

Dr. Gabriel Mannis will answer the question "How is venetoclax dosed?"

12:15 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Mary Arnett

Mary Arnett

Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Healthtree contact Catherine Lai, MD, MPH

Catherine Lai, MD, MPH

After completing internal medicine residency at the University of Illinois Chicago, Dr. Lai completed a fellowship in hematology/oncology at the National Cancer Institute of the National Institutes of Health. Dr. Lai also received her master’s in Public Health in Epidemiology from George Washington University. Prior to joining Penn, Dr. Lai served as the Director of Leukemia at MedStar Georgetown University Hospital’s Lombardi Comprehensive Cancer Center in Washington, DC. In her current role, she is the Physician Leader of the Leukemia Clinical Research Unit and Medical Director of the outpatient hematologic malignancies clinic. She is also Co- Director of the Penn Geriatric Oncology Core which focuses on the complete care of older adults with cancer.
Healthtree contact Gabriel Mannis, MD

Gabriel Mannis, MD

Dr. Mannis is Assistant Professor of Medicine in the Division of Hematology at Stanford University School of Medicine, and Medical Director of Stanford’s Inpatient Leukemia Service. He specializes in the treatment of acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), and other hematologic malignancies. As a clinical scientist, Dr. Mannis divides his time between caring for patients, teaching trainees, and researching novel therapies for AML and MDS.